Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 29, 2026

CSW Industrials Q3 2026 Earnings Call Transcript

View original at finance.yahoo.com
CSW Industrials Q3 2026 Earnings Call Transcript Image source: The Motley Fool. DATE Thursday, Jan. 29, 2026 at 10 a.m. ET CALL PARTICIPANTS Chairman, President, and Chief Executive Officer — Joseph B…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Mars Parts expected to exceed $10M run-rate synergies target

    80% confidence
  • Expect easier comparisons in coming quarters as Q4 FY2025 was +8%

    80% confidence
  • Some customers are continuing destocking through Q4

    80% confidence
  • Toronto high-rise residential market has dried up but existing backlog is converting

    80% confidence
  • December exit rate and January orders were encouraging versus Q3

    80% confidence
  • Transaction expenses mostly behind; integration expenses continuing

    80% confidence
  • Q3 inventory write-off was one-time, related to terminated distribution relationship

    80% confidence
  • Historical CS organic growth is mid-to-high single digits through the cycle

    80% confidence
  • All capital allocation levers available pending disciplined risk-adjusted analysis

    80% confidence
  • Company is cautiously optimistic for FY2027 with better visibility expected on May earnings call

    80% confidence
  • Mars Parts on track to exceed target 30% EBITDA margin within 12 months

    80% confidence
  • Existing home sales showing some green shoots while new construction remains soft

    80% confidence
  • Commercial construction market for EBS continues to be challenging

    80% confidence
  • Synergy realization is in first couple innings for margins and middle innings for actioning

    80% confidence
  • New product development is a key organic growth driver for EBS

    80% confidence
  • Customer destocking is nearing completion based on detailed customer discussions

    80% confidence
  • Digestion period for M&A will be quarters, not years

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com